Relationship between CYP2E1 Polymorphism and Increase of ALT Activity during Therapy of Patients with Pulmonary Tuberculosis
- 13 October 2011
- journal article
- research article
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 151 (6) , 741-746
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Role of polymorphic N‐acetyl transferase2 and cytochrome P4502E1 gene in antituberculosis treatment‐induced hepatitisJournal of Gastroenterology and Hepatology, 2011
- Genetic Polymorphism in CYP2E1: Population Distribution of CYP2E1 ActivityJournal of Toxicology and Environmental Health, Part B, 2009
- Biomarkers of Human Exposure to Acrylamide and Relation to Polymorphisms in Metabolizing GenesToxicological Sciences, 2009
- Human N-Acetyltransferases and Drug-Induced HepatotoxicityCurrent Drug Metabolism, 2008
- Pharmacogenomics of Anti-TB Drugs-Related HepatotoxicityPharmacogenomics, 2008
- Genetic polymorphisms of drug-metabolizing enzymes and the susceptibility to antituberculosis drug-induced liver injuryExpert Opinion on Drug Metabolism & Toxicology, 2007
- Suppression of Cytochrome P450 2E1 Promoter Activity by Interferon-γ and Loss of Response Due to the -71G>T Nucleotide Polymorphism of the CYP2E1*7B AlleleThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Cytochrome P450 2E1 Genotype and the Susceptibility to Antituberculosis Drug–Induced HepatitisHepatology, 2003
- Structural and Functional Characterization of the 5′-Flanking Region of the Rat and Human Cytochrome P450 2E1 Genes: Identification of a Polymorphic Repeat in the Human GeneBiochemical and Biophysical Research Communications, 1999